All News #Library
Rare Diseases
Bayer Initiates Phase 2 Trial For Alport Syndrome Treatment
04 Dec 2025 //
PHARMIWEB
Evotec, Immuneering To Collaborate On Ligand Identification For Rare Diseases
21 Nov 2018 //
DRUG DISCOVERY ONLINE

Market Place
Sourcing Support